|
Pressure rises in cardio
Norvasc News - Med Ad News (subscription), PA - Feb 17, 2009
... the active chemical in the calcium channel blocker Norvasc; and valsartan, which is the active chemical in the angiotensin II receptor blocker Diovan. ...
Pfizer Earnings Call, Fourth Quarter 2008
Norvasc News - 123Jump.com, FL - Feb 3, 2009
The decrease was driven by the negative impact of the loss of US exclusivity of Zyrtec and Camptosar and the loss of exclusivity for Norvasc in Korea and ...
Pfizer Reports Fourth-Quarter and Full-Year 2008 Results and 2009 ...
Norvasc News - MarketWatch (press release) - Jan 26, 2009
Zyrtec, Camptosar and Norvasc fourth-quarter 2008 revenues decreased by $515 million ($263 million, $144 million and $108 million, respectively), ...
Whopper of a merger for Wyeth, Pfizer ? but questionable long-term ...
Norvasc News - Local Tech Wire, SC - Feb 12, 2009
The hypertension therapy Norvasc (amlodipine) lost patent exclusivity in 2007, as did the Zyrtec (cetirizine) franchise, indicated for allergic rhinitis. ...
OTC Select Announces NYSE End-of-Day Daily Stock Watch
Norvasc News - Trading Markets (press release), CA - Feb 10, 2009
Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; ...
Concern ripples from Wyeth merger
Norvasc News - Madison Eagle, NJ - Jan 30, 2009
... with annual sales of $1 billion or more, including Prevnar, Effexor, Detrol, Lyrica for fibromyalgia and nerve pain, and blood pressure drug Norvasc. ...
Pharmas offer gloomy 2009 forecasts
Norvasc News - FiercePharma, DC - Jan 27, 2009
That's from generic competition on Norvasc, Zyrtec and Camptosar, MarketWatch reports. And 2009 forecasts look grim: Pfizer predicts a revenue decline to ...
Search Engines Used At More Points Along the Treatment Continuum ...
Norvasc News - PharmaLive.com (press release), PA - Feb 11, 2009
... Lamisil, Lantus, Lexapro, Levitra, Lipitor, Lunesta, Nasacort, Nasonex, Neulasta, Neurontin, Nexium, Norvasc, NuvaRing, Ortho Evra, Ortho Tri-Cyclen Lo, ...
Manhattan Research Releases Top Pharma Brand Product Sites by ...
Norvasc News - PR Web (press release), WA - Feb 3, 2009
... Lamisil, Lantus, Lexapro, Levitra, Lipitor, Lunesta, Nasacort, Nasonex, Neulasta, Neurontin, Nexium, Norvasc, NuvaRing, Ortho Evra, Ortho Tri-Cyclen Lo, ...
High Growth Reported for The Cardiovascular Market: Competitive ...
Norvasc News - MarketWatch (press release) - Feb 10, 2009
Norvasc was the leading anti-hypertensive, with sales of $3.3bn. -- The global market for anticoagulants will experience significant activity over the next ... Page : 1 2 3 |